Silberstein Alzheimer鈥檚 Institute
In the 1980s, through the generosity of William and Sylvia Silberstein and the Silberstein Foundation, a dedicated research center to study Alzheimer鈥檚 disease and memory disorders was formed at 觅圈资源站 Langone: the world-renowned Silberstein Alzheimer鈥檚 Institute.
Located within 觅圈资源站 Langone鈥檚 , the Silberstein Alzheimer鈥檚 Institute focuses on the prevention, diagnosis, and treatment of Alzheimer鈥檚 disease and age-related cognitive decline through research, public education, and clinical care. The Silberstein Alzheimer鈥檚 Institute houses the National Institutes of Health (NIH) , the Pearl I. Barlow Center for Memory Evaluation and Treatment, translational research programs, and provides support programs for caregivers.
The ARDC conducts research into Alzheimer鈥檚 disease and related disorders, as well as clinical trials into new medications and treatments for memory loss. Of the 37 NIH-supported ADRCs, ours is one of the oldest and largest in the United States and has been funded by the National Institute on Aging for 28 years.
Through the ADRC at the Silberstein Alzheimer鈥檚 Institute, patients can participate in a long-term study examining the progression of Alzheimer鈥檚 disease. The ADRC provides treatment and care for participants with memory disorders caused by neurological, psychological, and physical ailments, as well as memory issues resulting from the normal aging process.
Patients participating in our clinical trials receive treatment for their condition through the Pearl I. Barlow Center for Memory Evaluation and Treatment. Now regarded as one of New York City鈥檚 most comprehensive diagnostic and treatment centers for patients with memory disorders of all origins, the center delivers the highest level of medical and neurological care.
We also understand that one of the best ways we can help patients is by helping their caregivers. Through our support groups and counseling, we give caregivers the tools they need to maintain their important roles.